RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides
about
Structural insights into calcium-bound S100P and the V domain of the RAGE complexTherapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibodyS100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE)Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamidesReceptor for advanced glycation end products and its involvement in inflammatory diseasesS100A13. Biochemical characterization and subcellular localization in different cell linesThe structure of Ca2+-loaded S100A2 at 1.3-Å resolutionChemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and functionStructural and functional insights into RAGE activation by multimeric S100BInteraction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE)Structural insights into the oligomerization mode of the human receptor for advanced glycation end-productsS100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domainsAdvanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cellsDistinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end productsAtherosclerosisConformational and thermodynamic properties of peptide binding to the human S100P proteinMyeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI ...Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cellsRAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesisNeutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel diseaseSensitization of interferon-gamma induced apoptosis in human osteosarcoma cells by extracellular S100A4Regulation of S100A8/A9 (calprotectin) binding to tumor cells by zinc ion and its implication for apoptosis-inducing activity.Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory controlSoluble RAGE: a hot new biomarker for the hot joint?RAGE Expression and ROS Generation in Neurons: Differentiation versus DamageNovel concepts on pregnancy clocks and alarms: redundancy and synergy in human parturitionThe life and works of S100P - from conception to cancerThe clearance of dying cells: table for twoSoluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary SyndromeScavenger Receptors: Emerging Roles in Cancer Biology and ImmunologyDietary advanced glycation end products and their role in health and diseaseManganese homeostasis and utilization in pathogenic bacteriaRole of advanced glycation end products in cellular signalingNew insights into the regulation of neutrophil NADPH oxidase activity in the phagosome: a focus on the role of lipid and Ca(2+) signalingS100A8 and S100A9 in cardiovascular biology and diseaseThe 1.5 A Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE) Ectodomains Reveals Unique Features Determining Ligand BindingStructural Basis for Ligand Recognition and Activation of RAGEAdvanced Glycation End Product Recognition by the Receptor for AGEs
P2860
Q21131976-9DC6AB4E-019E-445E-9352-820209995123Q21132534-2835E576-ECD0-4167-B9A2-E354689DAFFEQ21135467-B05D8EB6-A122-4DF8-ABD7-5593AF0ACAA1Q21145828-37BD2B31-5B21-4A2A-986D-6514800F70BEQ21285070-69EDCABC-FCA2-47A8-9FB1-7CE889B8E1E9Q22253345-56AB98D0-0CB7-4F2F-B54F-15C9EDC58310Q24306778-76A873F8-6A83-46FE-BBF1-41B210BE7C80Q24310573-C762FFAB-8064-4C96-B64C-9A39C4ECDEC1Q24318378-E315AAE2-4B41-4DF8-A834-9B83A3155F79Q24322846-F01B7B48-8F78-4605-9FB3-1F1B126DA16CQ24323192-6B134C30-74E2-4C30-BE23-FD378C4709F1Q24337632-FB87BD30-336B-4BCA-93CE-A8947BF32B00Q24338271-4D942301-115E-452D-AD0D-86D6F65A1060Q24338574-38ACD178-CA84-47B2-B127-233D674B6414Q24563997-CEC2F2E7-06A1-4AF6-AC2C-D1089E06D616Q24643454-D2DF1815-B61B-4575-80F6-623BC3250616Q24644573-52D17340-AF79-43DE-921A-CAF6C2C60233Q24644962-9B26799C-4C9B-4270-BEF5-1482BF8DD81CQ24650933-5ED2DEA7-0F5A-48CD-82EE-A2D4F600DF83Q24658240-B8C33E87-1F65-4300-8DAD-981112F59945Q24658378-A171C264-3753-40B8-BD97-2FAD1326F450Q24669692-397B8858-4FE5-4CB2-BB70-583B74113930Q24804328-083B6034-142A-4D72-9342-E50F3F19E1EFQ24815095-41F256CE-D4F7-47F9-96D2-D0691F7C2716Q24817102-2B08A7E4-7E76-438F-BBC5-84289DA7BA1CQ24817185-3A1F0FB6-DED1-45E9-AB15-B83F2CA526AAQ26744630-509C1EA9-BEF7-4AB2-A5DC-B4F8B7D2799DQ26745938-62144D5F-EC13-4713-84C0-7D537D230200Q26749135-7B56D158-F1FA-4595-968F-EAB2C46FABA5Q26753825-437F67FA-218A-4880-9B27-2809B783AE6FQ26780488-A0D078B7-3A33-4868-B6D8-BCACAE3180E4Q26799114-9BC647CD-FF4A-4AE6-B626-3C30DEF6CAA4Q26801247-F07CAB50-E2A2-4FD5-9DF9-79502780F2B3Q26852442-A8FACC50-96B4-4DCE-82E8-6BA8F3783AD5Q27003423-A140ABDD-14FB-41EB-B034-BF24C874C5CBQ27004060-35CB6C92-CC13-432B-93E4-9CD798BBFF87Q27024450-BFC44DC3-7528-4199-8B23-C7C4F7E8E49CQ27664995-55F00C7B-CC38-421C-872C-C711EBE62959Q27665039-409CCABC-4FF9-4FB6-845A-A50382F0BDACQ27667822-8FD9A342-46DF-40D2-8761-5446548006E8
P2860
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
RAGE mediates a novel proinfla ...... S100/calgranulin polypeptides
@ast
RAGE mediates a novel proinfla ...... S100/calgranulin polypeptides
@en
RAGE mediates a novel proinfla ...... S100/calgranulin polypeptides
@en-gb
RAGE mediates a novel proinfla ...... S100/calgranulin polypeptides
@nl
type
label
RAGE mediates a novel proinfla ...... S100/calgranulin polypeptides
@ast
RAGE mediates a novel proinfla ...... S100/calgranulin polypeptides
@en
RAGE mediates a novel proinfla ...... S100/calgranulin polypeptides
@en-gb
RAGE mediates a novel proinfla ...... S100/calgranulin polypeptides
@nl
prefLabel
RAGE mediates a novel proinfla ...... S100/calgranulin polypeptides
@ast
RAGE mediates a novel proinfla ...... S100/calgranulin polypeptides
@en
RAGE mediates a novel proinfla ...... S100/calgranulin polypeptides
@en-gb
RAGE mediates a novel proinfla ...... S100/calgranulin polypeptides
@nl
P2093
P921
P3181
P1433
P1476
RAGE mediates a novel proinfla ...... S100/calgranulin polypeptides
@en
P2093
A Bierhaus
A M Schmidt
M A Hofmann
P304
P3181
P356
10.1016/S0092-8674(00)80801-6
P407
P577
1999-06-25T00:00:00Z